Valuation: CeriBell, Inc.

Market Cap 753M 660M 609M 562M 1.07B 71.96B 1.09B 7.3B 2.84B 35.28B 2.83B 2.77B 122B P/E 2026 *
-11.4x
P/E 2027 * -16.9x
Enterprise Value 740M 648M 598M 553M 1.05B 70.69B 1.07B 7.17B 2.79B 34.66B 2.78B 2.72B 120B EV / Sales 2026 *
6.49x
EV / Sales 2027 * 4.99x
Free-Float
87.13%
Yield 2026 *
-
Yield 2027 * -
1 day-2.27%
1 week-0.26%
Current month-0.26%
1 month+6.30%
3 months+8.56%
6 months-15.02%
Current year-11.54%
1 week 19.04
Extreme 19.04
20.46
1 month 17.07
Extreme 17.07
20.76
Current year 15.84
Extreme 15.84
24.33
1 year 10.85
Extreme 10.85
24.33
3 years 10.01
Extreme 10.01
32.75
5 years 10.01
Extreme 10.01
32.75
10 years 10.01
Extreme 10.01
32.75
Manager TitleAgeSince
Chief Executive Officer 46 2015-09-30
Director of Finance/CFO 44 2020-03-31
Chief Operating Officer - 2019-07-31
Director TitleAgeSince
Chairman 65 2024-05-31
Director/Board Member 66 2022-05-31
Director/Board Member 62 2025-09-21
Date Insider Type Main position Quantity % Market Cap.
06-29Sell

Director

-2,207 0.0058%
06-25
TPG Group Holdings (SBS) Advisors, Inc.
SellCompany -202,368 0.5334%
06-10Sell

Director

-5,500 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
-2.27%-0.26%+12.79% - 753M
+0.20%+5.37%-9.97%+24.58% 4.11B
-3.77%+5.35%+81.69% - 1.63B
-7.15%-15.96%+72.70%+73.00% 128M
-6.94%+11.81%+4.55%+15.83% 78.29M
Average -3.03%+5.90%+32.35%+37.80% 1.34B
Weighted average by Cap. -1.21%+5.79%+16.59%+25.85%

Financials

2026 *2027 *
Net sales 114M 99.84M 92.13M 85.13M 162M 10.89B 164M 1.1B 430M 5.34B 428M 419M 18.53B 146M 128M 118M 109M 207M 13.94B 210M 1.41B 550M 6.83B 548M 536M 23.71B
Net income -65.38M -57.26M -52.84M -48.83M -92.65M -6.25B -94.34M -633M -246M -3.06B -246M -240M -10.63B -44.3M -38.8M -35.8M -33.08M -62.77M -4.23B -63.92M -429M -167M -2.08B -166M -163M -7.2B
Net Debt -13.26M -11.61M -10.72M -9.9M -18.79M -1.27B -19.13M -128M -49.98M -621M -49.79M -48.7M -2.16B -24.76M -21.69M -20.01M -18.49M -35.09M -2.37B -35.73M -240M -93.35M -1.16B -92.99M -90.95M -4.03B
Logo CeriBell, Inc.
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its hardware is composed of disposable, flexible headbands and head caps (Wearables) and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals. EEG data captured by the recorder are interpreted by its proprietary AI-powered seizure detection algorithms, which monitor the patient’s EEG signal and support the clinician’s real-time assessment of seizure activity.
Employees
327
Date Price Change Volume
26-07-08 US$19.40 -2.27% 255,547
26-07-07 US$19.85 +0.30% 466,145
26-07-06 US$19.79 +1.23% 360,637
26-07-02 US$19.55 -2.25% 721,374
26-07-01 US$20.00 +2.83% 322,780
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
19.85USD
Average target price
26.86USD
Spread / Average Target
+35.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CBLL Stock